851107-28-3

Basic information

• Product Name: 9a-(4-chlorobenzyl)-7-hydroxy-4-(4-(2-(piperidin-1-yl)ethoxy)phenyl)-1,2,9,9a-tetrahydro-3H-fluoren-3-one
• Synonyms: 9a-(4-chlorobenzyl)-7-hydroxy-4-(4-(2-(piperidin-1-yl)ethoxy)phenyl)-1,2,9,9a-tetrahydro-3H-fluoren-3-one;CMP8
• CAS NO: 851107-28-3
• Molecular Formula: C33H34ClNO3
• Molecular Weight: 528.08096
• EINECS: -0
• Mol File: 851107-28-3.mol

Chemical Properties

• Boiling Point: 703.5±60.0 °C(Predicted)
• Appearance: /
• Density: 1.30±0.1 g/cm3(Predicted)
• PKA: 9.46±0.40(Predicted)
• CAS DataBase Reference: 9a-(4-chlorobenzyl)-7-hydroxy-4-(4-(2-(piperidin-1-yl)ethoxy)phenyl)-1,2,9,9a-tetrahydro-3H-fluoren-3-one(CAS DataBase Reference)
• NIST Chemistry Reference: 9a-(4-chlorobenzyl)-7-hydroxy-4-(4-(2-(piperidin-1-yl)ethoxy)phenyl)-1,2,9,9a-tetrahydro-3H-fluoren-3-one(851107-28-3)
• EPA Substance Registry System: 9a-(4-chlorobenzyl)-7-hydroxy-4-(4-(2-(piperidin-1-yl)ethoxy)phenyl)-1,2,9,9a-tetrahydro-3H-fluoren-3-one(851107-28-3)

Safety Data

• Hazardous Substances Data: 851107-28-3(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
9a-(4-chlorobenzyl)-7-hydroxy-4-(4-(2-(piperidin-1-yl)ethoxy)phenyl)-1,2,9,9a-tetrahydro-3H-fluoren-3-one is used as a potential pharmaceutical candidate for various applications due to its unique structure and functional groups that may impart biological activity.
The physical and chemical properties, as well as the potential uses of 9a-(4-chlorobenzyl)-7-hydroxy-4-(4-(2-(piperidin-1-yl)ethoxy)phenyl)-1,2,9,9a-tetrahydro-3H-fluoren-3-one, would need to be further investigated and characterized through chemical analysis and biological testing to fully understand its capabilities and applications in the pharmaceutical industry.

Upstream product

• 104-88-1 4-chlorobenzaldehyde 
• 3040-44-6 1-piperidinoethanol 
• 851107-70-5 9a-(4-chlorobenzyl)-4-(4-hydroxyphenyl)-7-methoxy-1,2,9,9a-tetrahydro-3H-fluoren-3-one 
• 851107-65-8 C₁₇H₁₃ClO₂ 
• 1360452-59-0 C₂₁H₂₁ClO₃ 
• 1360452-63-6 9a-(4-chlorobenzyl)-7-methoxy-4-{4-[(tetrahydro-2H-pyran-2-yl)oxy]phenyl}-9,9a-dihydro-1Hfluoren-3(2H)-one 
• 182281-01-2 4-(tetrahydro-2H-pyran-2-yloxy)phenylboronic acid 
• 5111-70-6 5-methoxy-1-indanone 
• 851107-69-2 9a-(4-chloro-benzyl)-7-methoxy-4-(4-methoxymethoxy-phenyl)-1,2,9,9a-tetrahydro-fluoren-3-one 
• 851107-68-1 4-bromo-9a-(4-chlorobenzyl)-7-methoxy-1,2,9,9a-tetrahydro-3H-fluoren-3-one 
• 851107-67-0 9a-(4-chloro-benzyl)-7-methoxy-1,2,9,9a-tetrahydro-fluoren-3-one 
• 851107-66-9 2-(4-chlorobenzyl)-5-methoxy-1-indanone 
• 851107-71-6 9a-(4-chloro-benzyl)-7-methoxy-4-[4-(2-piperidin-1-yl-ethoxy)-phenyl]-1,2,9,9a-tetrahydro-fluoren-3-one 

Relevant articles and documents

Destabilizing domains derived from the human estrogen receptor

Methods to rapidly and reversibly perturb the functions of specific proteins are desirable tools for studies of complex biological processes. We have demonstrated an experimental strategy to regulate the intracellular concentration of any protein of inter

A structure-guided approach to an orthogonal estrogen-receptor-based gene switch activated by ligands suitable for in vivo studies

A strategy to obtain a fully orthogonal estrogen-receptor-based gene switch responsive to molecules with acceptable pharmacological properties is presented. From a series of tetrahydrofluorenones active on the wild-type estrogen receptor (ER) an inactive